首页> 外文期刊>Journal of Crohn’s & colitis >The Patient Simple Clinical Colitis Activity Index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers
【24h】

The Patient Simple Clinical Colitis Activity Index (P-SCCAI) can detect ulcerative colitis (UC) disease activity in remission: A comparison of the P-SCCAI with clinician-based SCCAI and biological markers

机译:患者简单临床结肠炎活动指数(P-SCCAI)可以检测缓解期的溃疡性结肠炎(UC)疾病活动:P-SCCAI与基于临床医生的SCCAI和生物学标志物的比较

获取原文
获取原文并翻译 | 示例
           

摘要

Aim: To develop a patient-based Simple Clinical Colitis Activity Index (P-SCCAI) of ulcerative colitis (UC) activity and to compare it with the clinician-based SCCAI, C-reactive protein (CRP) and Physician's Global Assessment (PGA) of UC activity. Monitoring UC activity may give patients disease control and prevent unnecessary examinations. Methods: Consecutive UC patients randomly completed the P-SCCAI either before or after consultation. Gastroenterologists assessed patients' UC activity on the same day. Overall agreement between SCCAI and P-SCCAI was calculated with Spearman's Rho and Mann-Whitney U test. Agreement regarding active disease versus remission and agreement at domain level were calculated by percent agreement and kappa (κ). Results: 149 (response rate 84.7%) UC patients participated. P-SCCAI and SCCAI showed a large correlation (rs= 0.79). The medians (IQR) of the P-SCCAI (3.78;0-15) tended to be higher than those of the SCCAI (2.86;0-13), although this difference did not reach statistical significance (z = 1.71| p = 0.088). In 77% of the cases the difference between clinicians' and patients' scores was not clinically different (i.e. ≤ 2). Percentage agreement between clinicians and patients, judging UC as active or in remission, was 87%, rs= 0.66, κ= 0.66, indicating a substantial agreement. In general patients tended to report more physical symptoms than clinicians. C-Reactive protein (CRP) was found to have a significant association with both P-SCCAI and SCCAI (κ= 0.32, κ= 0.39 respectively) as was PGA (κ= 0.73 for both indices). Conclusions: The P-SCCAI is a promising tool given its substantial agreement with the SCCAI and its feasibility. Therefore, P-SCCAI can complement SCCAI in clinical care and research.
机译:目的:建立基于患者的溃疡性结肠炎(UC)活动的简单临床结肠炎活动指数(P-SCCAI),并将其与基于临床医生的SCCAI,C反应蛋白(CRP)和医师的整体评估(PGA)进行比较UC活动。监测UC活性可以控制患者的疾病并防止不必要的检查。方法:连续UC患者在咨询之前或之后随机完成P-SCCAI。胃肠病学家在同一天评估了患者的UC活动。通过Spearman的Rho和Mann-Whitney U检验计算出SCCAI和P-SCCAI之间的总体一致性。通过百分比一致性和kappa(κ)计算关于活动性疾病与缓解的一致性以及在域级别的一致性。结果:149例(反应率为84.7%)的UC患者参加了研究。 P-SCCAI和SCCAI显示出很大的相关性(rs = 0.79)。 P-SCCAI的中位数(IQR)(3.78; 0-15)倾向于高于SCCAI的中位数(IQR)(2.86; 0-13),尽管该差异未达到统计学显着性(z = 1.71 | p = 0.088) )。在77%的病例中,临床医生和患者评分之间的差异在临床上没有差异(即≤2)。判断UC为活动或缓解状态的临床医生和患者之间的百分比一致性为87%,rs = 0.66,κ= 0.66,表明存在实质性一致性。一般而言,患者往往比临床医生报告更多的身体症状。发现C反应蛋白(CRP)与P-SCCAI和SCCAI都有显着关联(分别为κ= 0.32,κ= 0.39)和PGA(两个指标均为κ= 0.73)。结论:P-SCCAI与SCCAI达成了实质性协议,并且具有可行性,因此它是一种很有前途的工具。因此,P-SCCAI可以在临床护理和研究中补充SCCAI。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号